Gene expression analysis of hepatic response induced by gentamicin in mice
MOLECULAR & CELLULAR TOXICOLOGY
Authors: Oh, Jung-Hwa; Park, Han-Jin; Hwang, Ji-Yoon; Jeong, Sun-Young; Lim, Jung-Sun; Kim, Yong-Bum; Yoon, Seokjoo
Abstract
Gentamicin is a broad-spectrum aminoglycoside antibiotic used in the treatment of bacterial infection. Although side effects of gentamicin such as nephrotoxicity and ototoxicity have been investigated, the information on the hepatic effects of gentamicin is still limited. In the present study, gene expression profiles were analyzed in the liver of gentamicin treated mice using Affymetrix GeneChip (R) Mouse Expression 430A 2.0 Array. Totally, 400 genes were identified as being either up- or down-regulated over 1.5-fold changes (P< 0.01) in the liver of gentamicin treated mice. Among these deregulated genes, 16 up-regulated genes mainly involved in transport (Kif5b, Pex14, Rab 14, Clcn3, and Necap 1) and 20 down-regulaited genes involved in lipid and other metabolisms (Hdlbp, Gm2a, Uroc1, and Dak) were selected using k-means clustering algorithm. The functional classification of differentially expressed genes represented that several stress-related genes were regulated in the liver by gentamicin treatment. This data may contribute in understanding the molecular mechanism in the liver of gentamicin treated mice.
Prenatal diagnosis of partial monosomy 2q (2q37.3 -> qter) and partial trisomy 10q (10q24.31 -> qter) of paternal origin associated with increased nuchal translucency and abnormal maternal serum screening results
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY
Authors: Chen, Chih-Ping; Liou, Jui-Der; Seow, Kok-Min; Chern, Schu-Rern; Wu, Peih-Shan; Chen, Shin-Wen; Wu, Fang-Tzu; Town, Dai-Dyi; Chen, Li-Feng; Wang, Wayseen
Abstract
Objective: We present prenatal diagnosis of terminal 2q deletion and distal 10q duplication of paternal origin in a fetus associated with increased nuchal translucency and abnormal maternal serum screening results. Case report: A 26-year-old woman who had experienced spontaneous abortion twice underwent amniocentesis at 16 weeks of gestation because of an increased nuchal translucency thickness of 3.5 mm at 12 weeks of gestation and abnormal maternal serum screening results of 2.573 multiples of the median (MoM) of free beta-human chorionic gonadotrophin (beta-hCG) and 1.536 MoM of pregnancy-associated plasma protein-A (PAPP-A) resulting in a trisomy 21 risk of 1:64. Amniocentesis revealed a derivative chromosome 2. Simultaneous array comparative genomic hybridization (aCGH) analysis on the DNA extracted from uncultured amniocytes revealed arr [hg19] 2q37.3 (238,294,223-242,782,258) x 1, 10q24.31q26.3 (102,018,246-135,426,386) x 3. Cytogenetic analysis of parental bloods revealed a karyotype of 46,XX in the mother and a karyotype of 46,XY,t(2;10)(q37.3;q24.3) in the father. The fetal karyotype was 46,XX,der(2)t(2;10)(q37.3;q24.3)pat. The pregnancy was terminated at 20 weeks of gestation, and a malformed fetus was delivered with facial dysmorphism. Postnatal analysis of the cord blood confirmed the results of prenatal diagnosis. The fetus had a 4.693-Mb deletion of 2q37.3 encompassing the genes of HDAC4, KIF1A, PASK, HDLBP, FARP2 and D2HGDH, and a 33.34-Mb duplication of 10q24.31-q26.3 encompassing the gene of NF kappa B2. Conclusion: First-trimester ultrasound and maternal serum biochemistry screening may help to identify an unexpected unbalanced familial translocation at prenatal diagnosis. (C) 2020 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.